Equity Index Funds Very High Risk Fund Managers: Anil Ghelani, Diipesh Shah
Equity Index Funds Very High Risk
The investment objective of the Scheme is to generate returns that are commensurate with the performance of the Nifty Healthcare Index, subject to tracking error. There is no assurance that the investment objective of the Scheme will be achieved.
Expert-managed portfolios tailored to your financial goals.
Estimation is based on the past performance
| Index Funds | 1M | 3M | 6M | 9M | 1Y | 2Y | 3Y | 4Y | 5Y | 10Y | ALL |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund returns | 0.33% | 0.7% | -2.76% | -2.23% | 0% | 0% | 0% | 0% | 0% | 0% | 2.38% |
| Category returns | 6.73% | -1.92% | -2.07% | -1.83% | 8.47% | 5.78% | 18.85% | 13.06% | 15.26% | 12.62% | N/A |
| Absolute returns | 0.33% | 0.7% | -2.76% | -2.23% | 0% | 0% | 0% | 0% | 0% | 0% | 2.38% |
| Rank within category | 194 | 49 | 88 | 96 | 159 | 80 | 54 | 35 | 16 | 2 | N/A |
| Total Schemes in Category | 196 | 192 | 183 | 173 | 158 | 79 | 53 | 34 | 15 | 1 | N/A |
| Index Funds | 2025 | 2026 |
|---|---|---|
| Yearly returns | N/A | -1.08% |
| Q1 returns | N/A | -3.03% |
| Q2 returns | N/A | 2.01% |
| Q3 Returns | -2.3% | N/A |
| Q4 Returns | 3.29% | N/A |
Expense ratio: 0.95%
Inclusive of GST
Exit load
NIL
| Alpha | -0.0968307 |
| Beta | 0.9905 |
| Sharpe Ratio | -0.256932 |
| Sortino Ratio | -0.432133 |
| R-Squared | 0.989 |
| Tracking Error | 0.0385 |
| Downside Risk | 8.9596 |
| Std. Deviation (Annualised) | 10.0643 |
| Index Funds | 1M | 3M | 6M | 9M | 1Y | 3Y | 5Y | 10Y | ALL | Fund Size (Cr) | Expense Ratio | Sharpe | Risk |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Motilal Oswal BSE Enhanced Value Index Fund - Regular Plan - Growth | 4.58% | -0.68% | 9.75% | 10.64% | 20.4% | 32.15% | 0% | 0% | 32.44% | 1,570.41 | 1.06 | 0.35 | Very High |
| ICICI Prudential NASDAQ 100 Index Fund - Growth | 7.86% | 6.74% | 13.07% | 24.08% | 57.27% | 31.61% | 0% | 0% | 18.02% | 2,773.20 | 1.06 | 0.37 | Very High |
| ICICI Prudential Nifty Auto Index Fund - Regular Plan - Growth | 5.21% | -4.21% | -3.17% | 10.02% | 23.75% | 26.38% | 0% | 0% | 23.2% | 190.90 | 1.00 | 0.31 | Very High |
| Kotak Nifty Smallcap 50 Index Fund - Regular Plan - Growth | 9.01% | 0.16% | -2.31% | -8.01% | 7.4% | 24.89% | 0% | 0% | 24.89% | 170.15 | 0.78 | 0.23 | Very High |
| Aditya Birla Sun Life Nifty Smallcap 50 Index Fund - Regular Plan - Growth | 9.35% | 0.41% | -2.06% | -7.78% | 7.7% | 24.88% | 15.11% | 0% | 15.07% | 234.13 | 1.04 | 0.25 | Very High |
| Axis Nifty Smallcap 50 Index Fund - Regular Plan - Growth | 9.29% | 0.37% | -2.11% | -7.83% | 7.66% | 24.71% | 0% | 0% | 14.81% | 512.37 | 1.02 | 0.24 | Very High |
| Motilal Oswal S&P 500 Index Fund - Regular Plan - Growth | 6.55% | 4.97% | 12.66% | 21.82% | 46.21% | 24.63% | 16.1% | 0% | 19.84% | 3,935.83 | 1.15 | 0.39 | Very High |
| Axis Nifty Midcap 50 Index Fund - Regular Plan - Growth | 8.49% | -0.92% | 1.78% | 1.13% | 14.16% | 24.17% | 0% | 0% | 18.71% | 565.91 | 1.01 | 0.28 | Very High |
| Edelweiss Nifty Midcap150 Momentum 50 Index Fund - Regular Plan - Growth | 7.56% | 0.64% | -0.52% | -1.77% | 8.98% | 23.23% | 0% | 0% | 18.55% | 1,333.36 | 1.11 | 0.25 | Very High |
| DSP Nifty Healthcare Index Fund - Regular Plan - Growth Current | 0.33% | 0.7% | -2.76% | -2.23% | 0% | 0% | 0% | 0% | 2.38% | 16.28 | 0.95 | -0.26 | Very High |
| Instrument Allocation | Instrument | Assets % |
|---|---|---|
|
|
Domestic Equities | 99.17% |
| Cash & Cash Equivalents and Net Assets | 0.83% |
| Sector Allocation | Sector | Assets % |
|---|---|---|
| Pharmaceuticals & Biotechnology | 78.77% | |
| Healthcare Services | 20.40% | |
| Others | 0.83% |
| Name | Sector | Instrument | Assets % |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 19.29% |
| Dr. Reddy's Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 7.93% |
| Apollo Hospitals Enterprise Ltd. | Healthcare Services | Domestic Equities | 7.91% |
| Divi's Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 7.83% |
| Max Healthcare Institute Ltd. | Healthcare Services | Domestic Equities | 7.42% |
| Cipla Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 7.14% |
| Lupin Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 5.82% |
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 4.58% |
| Fortis Healthcare Ltd. | Healthcare Services | Domestic Equities | 4.29% |
| Laurus Labs Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 4.00% |
| Aurobindo Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.78% |
| Glenmark Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.33% |
| Alkem Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.22% |
| Biocon Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.67% |
| Mankind Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.35% |
| Ipca Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.31% |
| Zydus Lifesciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.26% |
| Abbott India Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.40% |
| TREPS / Reverse Repo Investments | Cash & Cash Equivalents and Net Assets | 0.94% | |
| Piramal Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.88% |
| Syngene International Ltd. | Healthcare Services | Domestic Equities | 0.77% |
| Net Receivables/Payables | Cash & Cash Equivalents and Net Assets | -0.11% | |
| Total | 100.00% |
RETURNS
It is an Open ended scheme that primarily invests in Index Funds.
The investment objective of the Scheme is to generate returns that are commensurate with the performance of the Nifty Healthcare Index, subject to tracking error. There is no assurance that the investment objective of the Scheme will be achieved.
The scheme benchmark is the Nifty Healthcare Index - TRI
It is classified as Very High Risk, suitable for investors with a Very High risk appetite.
Returns Delivered by the funds are as follows:
1-year: 0%
3-year: 0%
5-year: 0%
Top holdings include names such as:
The NAV is around ₹10.24 (approx.) for the DSP Nifty Healthcare Index Fund - Regular Plan - Growth.
The fund’s AUM is approximately ₹16 Cr.
The expense ratio for the Regular Plan is 0.95.
NIL.
Minimum SIP starts at ₹100.
The minimum lump sum investment is ₹100. Often platforms may require higher in practice, but the statutory minimum remains the same.
You can start a SIP through:
Broker/agent platform like Sharescart.
Enter KYC details, choose the Regular Growth option, set SIP amount/frequency, and submit.
Yes. You can modify your SIP amount or frequency anytime online through the Sharescart platform.
You can redeem online via the Sharescart platform — choose the scheme, select the amount/units, and submit. Proceeds are credited to your bank account.
The fund managers: Anil Ghelani, Diipesh Shah
This fund is suitable for investors with a Very High risk tolerance.
Get personalized Portfolio Management Services designed to grow and protect your wealth.
ChatGPT
Claude
Perplexity
